Skip to content

Wearable Visual Cues in Parkinson's Disease

A Wearable Visual Cueing System for Gait Rehabilitation in Parkinson's Disease: a Randomized Controlled Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05478187
Enrollment
52
Registered
2022-07-28
Start date
2019-11-01
Completion date
2021-12-31
Last updated
2022-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait Disorders, Neurologic, Movement Disorders, Parkinson Disease

Keywords

visual cues, sensory cues, gait, balance, rehabilitation, Parkinson's disease, wearable device

Brief summary

One of the most disabling features of Parkinson's disease (PD) is represented by the gait disturbances. Some systematic reviews and meta-analysis have showed that conventional physical therapy might improve gait as well as balance, mobility and functional reach in subjects affected by PD. In addition, several studies and reviews support the effectiveness of external sensory cueing, by means of rhythmic auditory or visual cues, in improving kinematic parameters of gait (gait cadence, stride length, velocity, and postural stability) and the functional performance in people with PD, at least in the short-term. Specifically, cueing refers to the use of temporal or spatial stimuli to regulate movement and facilitate functional performance for individual with motor dysfunction. Basal ganglia act as internal triggers of neuronal activity in the supplementary motor area for well-learned, automatic movement sequences, such as locomotion. This mechanism is damaged in individuals with PD, and external cues may act as an attention resource to compensate the deficient internal rhythm due to basal ganglia dysfunction. Subjects can be coached in concentrating their attention on gait by specific self-prompting instructions or by cues stimulation or a combination of these. Movements generated by the presence of external sensory cues are prompted to use alternative (cortical, parieto-premotor) neuronal pathways which have not been damaged by neuronal degeneration of PD, bypassing the automatic basal ganglia network. Recent studies have provided preliminary evidence that visual cueing based on laser shoes and laser canes may reduce freezing, an established risk for falls, with improvement that can be observed for a variable period of time after rehabilitative intervention. In light of the evidence of effectiveness of cueing, developing wearable devices able to generate cues that match with step and that are effective, easy to use and low cost, would be challenging but very appropriate. The aim of this study was to investigate the non-inferiority of a wearable device producing visual cues (Q-Walk system, QUICKLYPRO s.r.l., Bergamo, Italy) in order to improve gait and balance PD patients, compared to a conventional training (stripes on the floor).

Detailed description

All patients consecutively referred to the Neurorehabilitation Unit of HABILITA between 1st November 2019 and 31th December 2021 were screened. Patient were admitted for outpatients rehabilitation. All particpants could walk independently without walking device. All patients were taking oral administration of levodopa, dopamine agonists, or both, and were evaluated in ON phase. All the patients gave their written informed consent to take part in the study. The study was approved by the Local Ethics Committee of Bergamo (Reg. Sper. n. 178/19, 11/10/2019) and was carried out in accordance with The Code of Ethics of the World Medical Association (Declaration of Helsinki) for experiments involving humans.

Interventions

DEVICEQWalk Study Group

10 individual sessions (5 sessions/week for 2 consecutive weeks). Each session consisted of 60 minutes of conventional physiotherapy plus an additional session of gait training (30 minutes), performed by means of the new wearable cueing system (QWalk)

OTHERTraditional visual cues - Control group

10 individual sessions (5 sessions/week for 2 consecutive weeks). Each session consisted of 60 minutes of conventional physiotherapy plus an additional session of gait training (30 minutes), performed by means of the traditional cues (stripes on the floor)

Sponsors

Habilita, Ospedale di Sarnico
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Intervention model description

Randomized Controlled Trial

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* diagnosis of idiopathic PD (defined by the UK Brain Bank Criteria); * absence of cognitive impairment (Mini-Mental State Examination score ≥ 24); * Hoehn & Yahr stage II-IV; mild to severe gait disturbance with score ≥2 at the Unified Parkinson's Disease Rating Scale (UPDRS) motor section III; * stable drug usage since at least 3 weeks.

Exclusion criteria

* past history or current presence of neurological conditions other than PD; * orthopedic or visual disturbances severely impairing walking ability; * previous deep brain stimulation or other neurosurgery; * participation in a rehabilitation program within 2 months before the trial and previous use of cues for gait rehabilitation.

Design outcomes

Primary

MeasureTime frameDescription
double support phase duration (%) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)Time of the sub-phase between heel contact of the phase to contralateral foot-off
mean gait speed (m/s) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)Distance covered by the body in the unit of time
step length (m) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)Distance measured from the heel print of one foot to the heel print of the other foot
cadence (step/min) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)time of steps per unit time
stance phase duration (%) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)time interval between two consecutive foot strikes of the same lower limb expressed as a percentage of the stride duration

Secondary

MeasureTime frameDescription
CoP sway length (statokinesigram) (mm) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)The projection onto a 2-dimensional space of the trajectory of the centre of pressure (COP) of a person during erect stance
mean CoP position along the anteroposterior direction (Eyes Open) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)the centroid of all the external forces acting on the plantar surface of the foot
mean CoP position along the mediolateral direction (Eyes Open) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)the centroid of all the external forces acting on the plantar surface of the foot
mean CoP position along the anteroposterior direction (Eyes Closed) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)the centroid of all the external forces acting on the plantar surface of the foot
mean CoP position along the mediolateral direction (Eyes Closed) changeChange from baseline (Time 0) at the end of the intervention (2 weeks - Time 1) and at the followup (3 months - Time 2)the centroid of all the external forces acting on the plantar surface of the foot

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026